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 1. Introduction 
Adolescence is a time of discovery and experimentation. It is also a period of physical and 
mental development when small changes can impact on the rest of a person‟s life. 
Adolescence is also the time when a large proportion of teenagers try alcohol(Smyth, Kelly, 
& Cox, 2011; Vega et al., 2002), tobacco(2002), and cannabis(Vega, et al., 2002) for the first 
time. Use of these substances during this period can often be detrimental to normal adult 
growth(Gruber, Sagar, Dahlgren, Racine, & Lukas, 2011; Tucker, 2009) and may result in 
chronic use leading to long-term health problems and early death(Schuppan & Afdhal, 
2008). The number of deaths attributable to addictive substances worldwide in 2004 was 
estimated to be over seven and a half million people(World Health Organisation, 2009). The 
same report showed that in Europe, 22.5% of all deaths in the region were directly caused 
by addictive substances, the highest percentage in any World Health Organisation (WHO) 
region in the world. There were 65,087 recorded drug-induced deaths due to illicit drugs 
alone in European Union (EU) member states between 2000 and 2008; with approximately 
16% of those deaths occurring in under 25s (EMCDDA, 2011). 
Ireland is similarly affected by substance use. Approximately 287 adolescents under the age 
of 19 years died in Ireland between 1998 and 2009, due to or as a consequence of 
substance use(Health Research Board, 2010, 2011a, 2011b). These statistics highlight the 
magnitude of substance use amongst the adolescent population in Ireland. Substance use in 
Ireland has been on the rise over the past decade; lifetime use of any illegal substance has 
risen by nearly 10% in the 15-34 years age category. Increased use of cannabis (up 9.6% to 
33.4%) and cocaine (doubled to 9.4%) are the most concerning trends identified from a 
recent report from the National Advisory Committee on Drugs (NACD)(National Advisory 
Committee on Drugs, 2011). A recent survey from United Nations International Children‟s 
Emergency Fund (UNICEF) reported that 38% of Irish 18-year-olds have taken drugs 
(defined in this survey as any substance except alcohol or tobacco) at some stage in their 
lives, and it rose to 44% for 20 year-olds(UNICEF Ireland, 2011). In the same survey, when 
asked if they were currently taking drugs, 28% admitted that they were.  
This widespread substance use in Irish society is placing an undeniably large burden on 
resources. Between 2005 and 2010, there were 2,295 recorded cases of adolescents under 
the age of 18, who utilised a drug treatment centre for the first time(Bellerose, Carew, & 
Lyons, 2011). This reflects an increase of over 50% in treatment demand over this five-year 
period. Large amounts of public funds and manpower have been invested in reducing 
availability of illegal substances in our society. Figures from the Central Statistics Office 
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(CSO) show that the number of cases of “possession of drugs for personal use” in 2010 was 
14,523, which is more than double the figure for 2004(Central Statistics Office, 2011). This 
database also shows a similar rise in the recorded number of cases of “possession of drugs 
with intent to supply”; 4,159 reported in 2010, almost twice the level recorded in 2004. There 
appears also to be a sharp increase in the domestic production of these substances to 
supply the high level of demand. In the same period of time as above, there was a 14-fold 
increase in the number of cases of “cultivation or manufacture of drugs”. This is a substantial 
challenge to the resources of An Garda Síochána, (Irish national police force). There are 
presently over 400 Gardaí involved in the Garda National Drugs Unit and in divisional units 
solely working to combat drug crime(C. Byrne, 2011). 
Persons who start experimenting with substances at an early age are more likely (i) to 
engage in polysubstance use(Lewinsohn, Rohde, & Brown, 1999), (ii) to have problem use 
later in life(Chen, Storr, & Anthony, 2009; Dawson, Goldstein, Chou, Ruan, & Grant, 2008), 
(iii) to suffer from health problems(Hart, Morrison, Batty, Mitchell, & Davey Smith, 2010), and 
(iv) to experience psychological problems(Tucker, 2009). Preventing or delaying the onset of 
experimentation could reduce the number of persons requiring medical treatment; thus 
potentially reducing the burden on the public health care system, and related healthcare 
expenditure. Furthermore, it would likely lead to a decrease in polysubstance use, which has 
been associated with increased mortality(Gossop, Stewart, Treacy, & Marsden, 2002) and 
has been implicated in approximately 50% of all substance-related deaths in Ireland 
between 2004 and 2009(Health Research Board, 2011a).  
The prevalence of substance use and the harm that is caused by young people is an area of 
concern for policy makers, health workers, the criminal justice system, youth workers, 
teachers and parents. It is therefore important to have a clear understanding of the extent of 
the problem. Whilst there have been studies which have examined this issue, there has not 
been a comprehensive review of the literature relating to substance use by young people in 
Ireland. We have therefore conducted a systematic review, to identify, synthesise and 
summarise the existing literature on the prevalence of substance use among adolescents 
and young adults in Ireland. The review will look at prevalence figures for the four most-used 
substances across the Republic of Ireland for persons between the age of 13 and 24, and 
compare usage across the years studied, 2000-2012.  
 
 
 
2. Methods 
This review was produced according to Preferred Reporting Items for Systematic reviews 
and Meta-Analyses (PRISMA) guidelines for systematic reviews and meta-analyses(Moher, 
Liberati, Tetzlaff, Altman, & The, 2009). These guidelines are primarily used for the reporting 
of controlled randomised trials (RCTs) or intervention studies, and so while not all items 
were applicable to this review of prevalence studies, the guidelines were adhered to as 
closely as possible. The articles were compiled from a large number of databases to ensure 
that as many relevant articles were included. The review was limited to articles reporting the 
use of cannabis, alcohol, nicotine, and benzodiazepines. These four substances were 
identified as the most widely-used substances in two recent large-scale studies(Currie et al., 
2008; B. Hibell et al., 2009). An age range of 13-24 years was used as the criteria for 
searching as it encompasses the National Library of Medicine‟s Medical Subject Headings 
(MeSH) definitions of an „adolescent‟ (13-18 years) and „young adult‟ (19-24 years)(National 
Center for Biotechnology Information, 2011). The following inclusion criteria were applied to 
the searches: English language, full-text access, and published since 2000. The databases 
searched with a Boolean string were: PubMed, Scopus, Web of Knowledge, Google Scholar, 
ERIC, Embase and CINAHL. The PubMed database was searched using the keywords as 
follows: adolescent or young adult, marijuana smoking, benzodiazepines, smoking, ethanol, 
Ireland. A search of the remaining databases was performed including the search terms: 
adolescent or young adult, cannabis or marijuana or benzodiazepine or alcohol or nicotine or 
tobacco or cigarette, and Ireland. These searches were conducted in December 2011 and 
updated thereafter to include relevant studies that were published after December 2011. An 
additional manual search of the National Documentation Centre on Drug Use was necessary 
as it did not allow searches using Boolean operators(Health Research Board, 2011c). This 
website is controlled by the Health Research Board (HRB) in Ireland and is a “database of 
Irish drug and alcohol research – an electronic library of full-text reports, journal articles, 
theses, and conference papers” (National Documentation Centre on Drug Use, 2012). This 
database has links to grey literature published by the government, national and international 
bodies. Personal contact was made with authors of some articles to obtain additional 
information. 
The eligibility of articles found by the database search was checked by searching the title 
and abstract of the articles. Duplicates and records that were found to be not relevant were 
excluded. Reasons for exclusion included: multiple papers publishing data from the same 
dataset, articles which were commentaries and not original research, articles which covered 
a range of ages but were not divided into age categories, and articles which were part of a 
multi-national study, but did not provide country-specific information for Ireland. If there was 
still doubt about the eligibility of a paper, it was included so that a detailed inspection could 
be done at the next stage. The next stage was to obtain full-text copies of the remaining 
articles, and do a further assessment for eligibility and relevance. The data points of interest 
were extracted from the full-text reports and compiled into summary tables (see Tables 1-5). 
The data points assessed were divided into two categories: study characteristics (sample 
size, sampling method, age range, region of sampling, and any other information that might 
influence the analysis of the survey), and study results (details of alcohol, tobacco, cannabis, 
and benzodiazepines). These study results would be the outcomes of interest for the review. 
Quality of the final articles was assessed using the Methodological Index for NOn-
Randomised Studies (MINORS) tool(Slim et al., 2003). The tool was customised for use in 
this review, and all the articles retrieved were assessed in a scale of 0-10 based on their 
methodological quality. The scoring of the studies can be seen in Table 1.  
 3. Results 
A total of 2,562 articles were found in the database search, and 11 were found in additional 
searches. The titles and abstracts for each article were reviewed and duplicates were 
removed. This reduced the number of remaining articles to 1,773. The next stage was to 
examine the title and abstracts of the remaining articles and eliminate those which did not 
match the eligibility criteria. 1,702 articles were discarded; 360 were excluded because the 
study wasn‟t investigating Irish young people, 1309 were excluded because they were not 
measuring drug prevalence, 10 were excluded because they measured prevalence in a 
different age group, 18 were excluded because they weren‟t original research i.e. editorials, 
literature reviews etc., and 5 were excluded because they were studies that were based on 
data used from previous studies. After the excluded articles were discarded, 71 remained. 
The full-text articles were then obtained and assessed for suitability. Fifty-four articles were 
excluded; 8 had no Ireland-specific data, 36 weren‟t substance use prevalence studies, 7 
had data from studies with age ranges that included ages over 24, 2 had data based on 
previous research, and 1 wasn‟t a research article. There were 18 articles included in the 
review. A PRISMA flow diagram (Figure 1) provides a summary of the stages, and the 
number of studies in  each stage(Moher, et al., 2009). The study characteristics for the 
papers included in the review are summarised in Table 1. One of the included studies was a 
randomised control trial (RCT) that measured the effect of a smoking prevention 
initiative(Share, Quinn, & Ryan, 2004). There were eleven observational studies that had 
partial or full randomisation in the sampling process(Currie, et al., 2008; Flanagan, Bedford, 
O' Farrel, & Howell, 2003; Bjorn Hibell et al., 2004; B. Hibell, et al., 2009; Björn Hibell et al., 
2012; Kabir, Manning, Holohan, Goodman, & Clancy, 2010; Kelleher, Cowley, & Houghton, 
2003; Manning et al., 2002; McNeill et al., 2011; Office of Tobacco Control, 2006; Smyth, et 
al., 2011), and one study employed cluster sampling(Morgan et al., 2008). Convenience 
sampling was used by three of the studies(O'Cathail et al., 2011; Palmer & O' Reilly, 2008; 
UNICEF Ireland, 2011), and the method of sample selection could not be identified in two 
studies(Curtin, 2004; Moran, Maguire, & Howell, 2000). Half of the studies surveyed the use 
of a single substance while the majority of the remaining studies investigated the use of 
three or more substances. Sixteen studies had tobacco as a substance studied, eleven 
studies investigated alcohol consumption, nine studies looked into cannabis use, and six 
investigated benzodiazepine use. 
To facilitate observation of trends over time, the studies are presented according to three 
time periods: Period 1 (2000-2006), Period 2 (2007-2009), and Period 3 (2010-2012). As 
fewer studies were published in the earlier years, Period 1 encompasses a longer timeframe 
of 7 years. Period 2 and 3 have equal timeframes of 3 years. These groupings provided 
approximately equal-sized groups, in terms of numbers of publications thereby avoiding 
issues such as diluting the group size to one or two articles.  
 
3.1. Tobacco Usage 
There were sixteen studies which collected data on tobacco usage, and a summary of the 
data can be seen in Table 2. One study was a RCT(Share, et al., 2004), eleven were 
observational studies with randomly selected participants(Currie, et al., 2008; Flanagan, et 
al., 2003; Bjorn Hibell, et al., 2004; B. Hibell, et al., 2009; Björn Hibell, et al., 2012; Kabir, et 
al., 2010; Kelleher, et al., 2003; Manning, et al., 2002; McNeill, et al., 2011; Office of 
Tobacco Control, 2006), one study used cluster sampling(Morgan, et al., 2008), two used 
convenience sampling(O'Cathail, et al., 2011; UNICEF Ireland, 2011) and two did not 
describe how participants were selected(Curtin, 2004; Moran, et al., 2000).  
Lifetime use of tobacco 
This was reported in over half of the studies.  
Period 1 (2000-2006): The levels from five studies in Period 1 ranged between 50-
67%(Curtin, 2004; Flanagan, et al., 2003; Bjorn Hibell, et al., 2004; Kelleher, et al., 2003; 
Share, et al., 2004). The variation in the levels may exist because four of the five studies 
were measuring regional populations. The only national study reported a lifetime usage level 
of 67%(Bjorn Hibell, et al., 2004). The largest of the regional studies reported a similar figure 
at the high end of the range, 61%, and so the true estimate probably lies in the somewhere 
in this region(Kelleher, et al., 2003).  
Period 2 (2007-2009): Two studies in Period 2 surveyed lifetime use: one of the studies 
measured usage in 13 year-olds and 15 year-olds and reported 26% and 50% 
respectively(Currie, et al., 2008), while the second study reported 52% in a survey of 15-16 
year-olds(B. Hibell, et al., 2009) Both of these studies were on a large scale and encompass 
national populations so their estimates would be close to the true figure.  
Period 3 (2010-2012): There were two studies from Period 3, and these studies estimated 
lifetime tobacco usage at 48% and 43% respectively. There were differences between the 
two studies however, the former study was conducted in Cork City(O'Cathail, et al., 2011) 
while the latter was a nation-wide study(Björn Hibell, et al., 2012). 
Smoking a cigarette by age 13 years 
The second category examined was smoking a cigarette by age 13 years. It has been shown 
that initiation of substance use prior to 13 years of age is associated with chronic substance 
use(Hawkins et al., 1997). There were seven studies that collected data on this. 
Period 1 (2000-2006): Four studies were published with results which ranged from 30-
50%(Flanagan, et al., 2003; Bjorn Hibell, et al., 2004; Kelleher, et al., 2003; Share, et al., 
2004) 
Period 2 (2007-2009): Two studies were published which both had similar levels of 
approximately 30%(Currie, et al., 2008; B. Hibell, et al., 2009). These studies had good 
study designs and used a national sample so the true level is likely to be close to this.  
Period 3 (2010-2012): A single study published reported a level of 21%(Björn Hibell, et al., 
2012). 
Smoking in the previous month. 
The third category examined was smoking in the previous month. This is considered a good 
indicator of regular use.  
Period 1 (2000-2006): The studies from Period 1 ranged from 19-39%(Curtin, 2004; Bjorn 
Hibell, et al., 2004; Kelleher, et al., 2003; Manning, et al., 2002; Moran, et al., 2000; Office of 
Tobacco Control, 2006; Share, et al., 2004). Some of the variation in this can be explained 
thus: the two studies with the lowest percentages, 19% and 21%, were phrased in a different 
manner(Manning, et al., 2002; Share, et al., 2004). They measured positive responses to a 
question relating to whether they were currently smoking. This is not a clearly defined 
question and may account for the lower percentage. Two of the studies did not clearly 
indicate how samples were picked(Curtin, 2004; Moran, et al., 2000), and so caution is 
advised when generalising the results from these studies. The final two studies gave 
estimates of smoking in the previous month to be 33% and 30% respectively, so the true 
level is likely to be near this figure(Bjorn Hibell, et al., 2004),(Kelleher, et al., 2003).  
Period 2 (2007-2009): The level of smoking in the previous month in Period 2 was measured 
in two studies, and was estimated to be 23%(B. Hibell, et al., 2009) for one and between 29 
and 40% for the other(Morgan, et al., 2008). The study was a large-scale, nationwide survey, 
and it is likely that the result is indicative of the true figure.  
Period 3 (2010-2012): Five studies were found from Period 3; it is difficult to make a direct 
comparison between them due to significant heterogeneity in the studies. Two studies 
recorded levels of 10.6% and 10.5% for 13-14 year-olds(Kabir, et al., 2010) and 13-15 year-
olds(McNeill, et al., 2011) respectively, even though the former study measured the 
percentage of young persons currently smoking, and the latter measured the percentage of 
young persons that smoke greater than once a week or more. Two studies measured the 
level in older adolescents, 15-17 year-olds and 16-20 year-olds and reported levels of 
18%(O'Cathail, et al., 2011) and 23%(UNICEF Ireland, 2011) respectively. Both of these 
studies however used convenience sampling to select their participants. The remaining 
study from Period 3 looked at 15-16 year-olds, and showed a level of 21%(Björn Hibell, et 
al., 2012). 
Daily tobacco use 
The final category examined was daily tobacco use.  
Period 1 (2000-2006): The range in data from Period 1 was 11-23%(Curtin, 2004; Flanagan, 
et al., 2003; Moran, et al., 2000; Share, et al., 2004). However, caution should be exercised 
when interpreting results of the studies reporting the two highest levels, 23%(Moran, et al., 
2000) and 19%(Curtin, 2004), as the method of sample selection was not specified in the 
paper. The remaining two studies had good design; however they were both regional studies 
and so may not give a good indication of the national estimate.  
Period 2 (2007-2009): There were two studies from Period 2 and both studies reported two 
levels; the first study reported one for 13 year-olds, 3%, and one for 15 year-olds, 
15%(Currie, et al., 2008). The second study reported on levels of 18-19 year-olds, 23%, and 
20-24 year-olds, 31%(Morgan, et al., 2008). These are nationally representative studies and 
have good design so it is likely that they approximate the national level closely. 
Period 3 (2010-2012): None of the studies from Period 3 reported levels of daily smoking. 
3.2. Alcohol Usage 
There were eleven studies that looked into alcohol usage and a summary is provided in 
Table 3. Randomised sample selection was used in seven of the studies(Currie, et al., 2008; 
Flanagan, et al., 2003; Bjorn Hibell, et al., 2004; B. Hibell, et al., 2009; Björn Hibell, et al., 
2012; Kelleher, et al., 2003; Smyth, et al., 2011), convenience sampling was used for 
two(Palmer & O' Reilly, 2008; UNICEF Ireland, 2011), cluster sampling in one study(Morgan, 
et al., 2008), and the method of sample selection was not described in one of the 
studies(Curtin, 2004).  
Lifetime use of alcohol 
For lifetime use of alcohol, the figures varied both between and within these periods.  
Period 1 (2000-2006): There were four studies published in Period 1, and their levels ranged 
from 71-92%(Curtin, 2004; Flanagan, et al., 2003; Bjorn Hibell, et al., 2004; Kelleher, et al., 
2003). Differences in levels in these studies can in part be attributed to the age range of the 
participants. The studies with the lowest figure had a participant age ranging from 12-19 
years, while each of the others studies had a minimum age of 14 or 15 years.  One of the  
studies reported a lifetime level of 82%, but this study was conducted in County Cork with an 
unknown method of sampling, so it is difficult to extrapolate from it(Curtin, 2004). Two 
studies demonstrated close agreement at 92% and 90% levels for lifetime usage and the 
true level is likely to be close to this(Bould et al., 2007; Bjorn Hibell, et al., 2004).  
Period 2 (2007-2009): Only two of the three studies in Period 2 had data relating to lifetime 
alcohol usage and both of those studies reported similar results: 86.1% and 86%(B. Hibell, 
et al., 2009; Palmer & O' Reilly, 2008).  
Period 3 (2010-2012): There were three studies published in Period 3 and they reported 
77%, 58% and 81% usage (Björn Hibell, et al., 2012; Smyth, et al., 2011; UNICEF Ireland, 
2011). The wide discrepancy between these figures may be due to the age of participants; 
up to 20 years in one study(UNICEF Ireland, 2011) and up to 16 years for the latter 2 
studies. Another reason could be the nature of the studies: one was an internet poll and this 
may be a source of bias in the study(UNICEF Ireland, 2011). This contrasts with the third 
study which was a national study with randomised sampling(Björn Hibell, et al., 2012). 
Consumption of alcohol before 13 years of age 
Period 1 (2000-2006): This examined the percentage of young persons who first consumed 
alcohol before 13 years of age. A limitation with this category was that it was reported in only 
two studies. Unfortunately, one of the studies quoted percentages for three types of alcohol 
(beer, wine, and spirits) which ranged from 32-47%, so it was not possible to get an overall 
figure(Bjorn Hibell, et al., 2004). The remaining study reported an overall consumption level 
of 50%(Kelleher, et al., 2003).  
Period 2 (2007-2009): two studies from Period 2 reported on this category. One of the 
studies differentiated between alcohol types, which ranged from 21-33%(B. Hibell, et al., 
2009). The other study, Currie et al., reported a level of 38%(Currie, et al., 2008). Both of the 
studies were well-designed and were probably an accurate reflection of the actual population 
level.  
Period 3 (2010-2012): A single study from Period 3 reported levels of first consumption prior 
to 13 years of age at between 18% and 40% for the three types of alcohol mentioned 
above(Björn Hibell, et al., 2012). 
 
Alcohol use in previous 12 months 
Alcohol use in the previous 12 months was used as a measure of occasional use. Five 
studies (two from Period 1, two from Period 2, and one from Period 3) included data on 12 
month usage(Bjorn Hibell, et al., 2004; B. Hibell, et al., 2009; Björn Hibell, et al., 2012; 
Kelleher, et al., 2003; Palmer & O' Reilly, 2008).  
Period 1 (2000-2006): Both studies reported similar values, 88% and 83%(Bjorn Hibell, et 
al., 2004; Kelleher, et al., 2003). Both studies were large scale and had good design, so it 
probably reflects an estimate of the population figure.  
Period 2 (2007-2009): The two studies from Period 2 were in broad agreement with each 
other. Hibell et al. and Palmer et al. reported levels of 78% and 83% respectively(B. Hibell, 
et al., 2009),(Palmer & O' Reilly, 2008). The result from Palmer is a percentage of positive 
responses to the question if they drank once a year or more.  
Period 3 (2010-2012): The single study from Period 3 reported a level of 73% for alcohol use 
in the previous year(Björn Hibell, et al., 2012). 
 
Alcohol use in the previous month 
The final category related to alcohol use in the previous month. Only one of the most recent 
studies reported data, but there were data from six older papers (three from Period 1, two 
from Period 2, and one form Period 3)(Curtin, 2004; Bjorn Hibell, et al., 2004; B. Hibell, et al., 
2009; Björn Hibell, et al., 2012; Kelleher, et al., 2003; Morgan, et al., 2008; Palmer & O' 
Reilly, 2008).  
Period 1 (2000-2006): The studies from Period 1 reported a range of levels from 59-73%. 
The 59% figure comes from the paper by Curtin, which was a small County Cork study and 
the study design was unknown(Curtin, 2004). This affects the ability to generalise with its 
data and gives precedence to the results from the other studies which were 73% and 
62%(Bjorn Hibell, et al., 2004; Kelleher, et al., 2003).  
Period 2 (2007-2009): Hibell et al., 2008 had a level of 56% for the alcohol use in the 
previous month(B. Hibell, et al., 2009), while Palmer et al. gave a level of 62%(Palmer & O' 
Reilly, 2008). This final figure was the percentage of those that responded positively when 
asked if they drank alcohol once a month or more often.  
Period 3 (2010-2012): The study from Period 3 reported a level of 50% in this category(Björn 
Hibell, et al., 2012). 
3.3. Cannabis Usage 
A summary of the studies reviewed that included surveyed cannabis usage is displayed in 
Table 4. There were nine studies that reported cannabis use amongst adolescents and 
young adults in Ireland(Currie, et al., 2008; Flanagan, et al., 2003; Bjorn Hibell, et al., 2004; 
B. Hibell, et al., 2009; Björn Hibell, et al., 2012; Morgan, et al., 2008; Palmer & O' Reilly, 
2008; UNICEF Ireland, 2011). The studies were mostly randomised school surveys, while 
the remaining two studies were convenience studies(Palmer & O' Reilly, 2008; UNICEF 
Ireland, 2011). All of the studies measured lifetime use of cannabis and there was a wide 
variation between levels, 20-80%. The two highest usage levels, 80% and 41%, were 
reported by two studies that used convenience sampling, so the true level may differ(Palmer 
& O' Reilly, 2008; UNICEF Ireland, 2011). A pattern was seen in the other studies based on 
their year of publishing.  
 
 
 
Lifetime use of cannabis 
Period 1 (2000-2006): Earlier studies from Period 1 showed a usage level of between 29 and 
39%(Flanagan, et al., 2003; Bjorn Hibell, et al., 2004; Kelleher, et al., 2003). 
Period 2 (2007-2009): There were three studies in this period. Two of the studies had a level 
of 20%(Currie, et al., 2008; B. Hibell, et al., 2009), and the third study had a level of 
41.1%(Palmer & O' Reilly, 2008). 
Period 3 (2010-2012): There were two studies from Period 3 that reported on lifetime 
cannabis use. The most  recent European School Project on Alcohol and Other Drugs 
(ESPAD) study reported a level of 18%(Björn Hibell, et al., 2012), while the second report 
gave separate levels for the dried plant form (weed), >80%, and the extracted resin (hash), 
46%(UNICEF Ireland, 2011). These levels are largely different from levels reported at any 
time throughout the entire time range, and so their use as a representative figure must be 
cautioned. Overall, the levels are suggestive of a decreasing experimentation with cannabis 
amongst young people.  
Cannabis use in the previous 12 months 
A similar pattern was observed in the reporting of cannabis use in the previous 12 months.  
Period 1 (2000-2006): Higher levels were observed amongst the earlier studies, 25-
31%(Bjorn Hibell, et al., 2004; Kelleher, et al., 2003) than in subsequent periods. 
Period 2 (2007-2009): There were four studies in period two and these studies showed a 
decrease compared to earlier studies to 12-17%(Currie, et al., 2008; B. Hibell, et al., 2009; 
Morgan, et al., 2008). The exception to this is the study carried out by Palmer et al., which 
gives a level of 33% for 12 month usage(Palmer & O' Reilly, 2008). A possible explanation 
for this higher figure may be that the study covers a broader age range (14-19 years), and 
the level of use generally increases with age. Owing to problems with generalisation of this 
study, the true level is likely to be closer to Currie et al. and Hibell et al.(Currie, et al., 2008; 
B. Hibell, et al., 2009). 
Period 3 (2010-2012): A single study from Period 3 reported a level of 14%(Björn Hibell, et 
al., 2012).  
Cannabis use in the previous month 
 
Period 1 (2000-2006): The trends in cannabis use in the previous month paralleled those in 
use in the previous 12 months. The three studies from period one showed high levels of use, 
13-16% (Flanagan, et al., 2003; Bjorn Hibell, et al., 2004; Kelleher, et al., 2003). 
Period 2 (2007-2009): There were three studies compared with 7-14% respectively (Currie, 
et al., 2008; B. Hibell, et al., 2009; Palmer & O' Reilly, 2008). The highest of the more recent 
figures, (14%) is from Palmer et al., which as mentioned already suggests that the true level 
may be lower than this(Palmer & O' Reilly, 2008). 
Period 3 (2010-2012): There was one study in Period 3 that reported this data and the level 
was 7%(Björn Hibell, et al., 2012). 
3.4. Benzodiazepine Usage 
A summary of the studies reporting benzodiazepine usage can be found in Table 5. Four of 
the six studies had sample sizes greater than 2,000 and participants were randomly 
selected, so there is a high degree of confidence in the figures reported from these 
studies(Bjorn Hibell, et al., 2004; B. Hibell, et al., 2009; Björn Hibell, et al., 2012; Morgan, et 
al., 2008). None of these studies reported an overall prevalence level for benzodiazepine 
usage but instead categorised usage into prescription use and non-prescription use. The 
percentage of subjects who have tried benzodiazepines without the advice of a doctor was 
consistently higher than prescription use in each of the studies.  
Lifetime benzodiazepine use on prescription 
Period 1 (2000-2006): There were similar levels for the prevalence of lifetime prescription 
benzodiazepine use at 9.2% and 10.0%(Bjorn Hibell, et al., 2004; B. Hibell, et al., 2009; 
Björn Hibell, et al., 2012; Kelleher, et al., 2003). Variation in the figure can be attributed in 
part to the difference in participant age with one study carried out by Kelleher et al. ranging 
from 13-19 years(Kelleher, et al., 2003) while the rest had a narrower age range. Another 
contributing factor to the difference was that the participants in the Kelleher et al. study were 
recruited from three counties in the west of Ireland only, while the latter studies selected 
participants nationwide. This suggests that the higher end of the range is closer to the actual 
prevalence of non-prescription benzodiazepine use. 
Period 2 (2007-2009): There were two studies in this period(B. Hibell, et al., 2009; Morgan, 
et al., 2008). There was a wide discrepancy between the values gotten in these two studies. 
Period 3 (2010-2012): There was only one study in the third period, and this reported a level 
of use 9.0% (Björn Hibell, et al., 2012). 
Lifetime benzodiazepine use without prescription 
Period 1 (2000-2006): The levels ranged 2.0% to 5.6%, with the Kelleher et al. study 
reporting a level of 5.6% and the Hibell et al., 2004 study reporting 2%y(Bjorn Hibell, et al., 
2004; B. Hibell, et al., 2009; Kelleher, et al., 2003). 
Period 2 (2007-2009): There were 3 benzodiazepine studies that measured lifetime non-
prescription benzodiazepine use. Two of the studies had reported differing levels of usage. 
One of the studies reported a level of 3.0%(B. Hibell, et al., 2009), while the other reports 
between 0 and 1.4% usage(Morgan, et al., 2008). One of the studies reported both 
prescription and non-prescription benzodiazepine use at 10.8%(Palmer & O' Reilly, 2008). 
This level appears to be in agreement with the rest of the studies; however the study cohort 
was not a national sample nor were the participants randomly selected. Both of these factors 
mean that generalisation of the results is not possible. 
Period 3 (2010-2012): There was a single study in Period 3, and it reported a level of 
3.0%(Björn Hibell, et al., 2012). 
4. Discussion 
4.1. Summary of Evidence 
This review examined available peer-reviewed research and other available reports on 
substance use in Irish young people since the year 2000. The review found a variety of 
studies that ranged from RCTs to online surveys and from small-scale rural studies to 
national studies. This allowed for a wide perspective on substance use. Some overall trends 
were observed in the literature. The clearest pattern that was elucidated was a trend towards 
a decrease in all substance use over time between Period 1, Period 2 and Period 3. This 
decrease in use was consistent between the first period and the most recent period. An 
explanation for this trend is not suggested by the majority of authors, though something may 
be learnt from their observations. One author suggests that the fall in tobacco usage levels 
may be attributed in part to tighter government restrictions on the sale, display, and usage of 
tobacco products(McNeill, et al., 2011). A likely significant factor to contribute to Ireland‟s 
decreasing substance use rates is the creation and publication of Ireland‟s first National 
Drug Strategy document in 2000 (Department of Tourism Sport & Recreation, 2000). It was 
the first time that a comprehensive and national approach to substance use was examined. 
There had been a report previous to this, Government Strategy to Prevent Drug Misuse 
1991 (Department of Health, 1991), but this had separate strategies for Dublin and the rest 
of the country. The National Drug Strategy paper introduced for the first time in Ireland the 
four pillar system. These pillars are supply, prevention, treatment, and research. This 
allowed resources to be allocated to areas where they are needed. It allowed “the bringing 
together of key agencies, in a planned and co-ordinated manner, to develop a range of 
appropriate responses to tackle drug misuse…” (Department of Tourism Sport & Recreation, 
2000). The report resulted in the creation of a National Awareness Campaign which used 
traditional media such as brochures and radio, and newer forms of promotion i.e. Facebook, 
Twitter and Drugs.ie website to increase awareness of the effects and consequences of 
substance use. The most recent National Drug Strategy document (Department of 
Community Rural and Gaeltacht Affairs, 2009) builds on the determination to lower 
substance use.  The biggest change in this report is the inclusion of alcohol as a drug of 
abuse. The high level of alcohol use nationally amongst adults and young people, and the 
cost to the public health system warranted its inclusion. Another stated reason for its 
inclusion was “For many, alcohol is also seen as a gateway to illicit drug use, particularly for 
young people, while poly -drug use - which very often includes alcohol - is now the norm 
among illicit drug users”. A recommendation in the report aimed at school students was the 
delivery of drug education to primary and post-primary students in schools through the 
Social, Physical, and Health Education (SPHE) curriculum.  
It would appear that the combination of more harsh sales restrictions and increased 
education and awareness has had its intended effect on drug levels. The efforts of those 
involved should be applauded, and their support should be continued to maintain this 
positive trend. This work should be augmented by international good practice such as the 
WHO‟s guidelines on reducing harmful alcohol use (World Health Organisation, 2010). 
These recommend implement various strategies should as pricing changes, closely 
regulating the advertisement of alcoholic drinks, and modifying the system of selling alcohol, 
such as reducing the hours of retails sales, and regulating the number and location of 
businesses that can sell alcohol. Further reduction in illicit substance use may come from 
educational interventions as outlined by Faggiano et al. 2005(Faggiano et al., 2005) and 
2010 (Faggiano et al., 2010). By continuing efforts such as these, the burden of substance 
use on young people can be reduced. 
As stated above, tobacco and alcohol use followed the trend of decreasing use across all 
measures of use, experimental, occasional, or regular. The fall in levels of use are a positive 
step in the reduction in the burden caused by “the single most preventable cause of death in 
the world today”; cigarettes(World Health Organisation, 2008), and reducing the level of total 
alcohol consumption amongst the Irish, who rank second highest in the EU and 15th highest 
in the world(World Health Organisation, 2011). Sustaining these trends could result in 
reduced burden on the healthcare system due to chronic treatment for preventable diseases, 
and on the justice system owing to reduced public order violations. The trend in decreasing 
tobacco use in Ireland mirrors that of Europe. The average lifetime use of tobacco for 15/16 
year-olds across the 34 countries included in the ESPAD study fell from 67% to 60% 
between 2003 and 2007(B. Hibell, et al., 2009). The same report gave a similar description 
for tobacco use in the previous month, and daily smoking; the former falling from 32% to 
28%, while the latter fell from 10% to 8%. An opposite trend was observed in relation to 
alcohol use. There was no change in the average lifetime use of alcohol from 2003 to 
2007(B. Hibell, et al., 2009), and the percentage of 15/16 year-olds who consumed alcohol 
in the previous month fell from 65% to 62% over the same four-year period. When looking 
broadly, it is positive to see a reduction of the levels of both experimental and regular use of 
these widely-available substances when compared to our European counterparts(B. Hibell, 
et al., 2009).  
There was a trend, amongst Irish adolescents, of decreased  lifetime cannabis use, use in 
the previous 12 months, and use in the previous month over the length of the study 
period(Bjorn Hibell, et al., 2004; B. Hibell, et al., 2009; Björn Hibell, et al., 2012). The pan-
European levels indicated by the latter report were similar to the levels of use in Ireland in 
2007(B. Hibell, et al., 2009). Ireland differs from the European average however as the level 
of Irish use decreased while the European level increased from 12% in 2003 to 19% in 2007. 
Most of this increase can be attributed to countries in the east of Europe, as the United 
Kingdom, France, Italy, Germany, Norway, Sweden, and Austria also had decreased lifetime 
cannabis use between 2003 and 2007. A similar pattern was observed in the category of 
cannabis use in the previous month(B. Hibell, et al., 2009). 
Benzodiazepine usage was unchanged across the time periods studied. European levels 
appear to vary from Irish levels according to the most recent survey of benzodiazepine 
usage(Björn Hibell, et al., 2012). The estimated average level of illicit benzodiazepine use 
was 6%, compared to 3% in Ireland. The level of prescribed use of benzodiazepines in 
Ireland was 1% higher than the European average of 8%. The levels of prescription and non-
prescription use in Ireland did not appear to have changed significantly throughout the years 
of reference of this review. An explanation that may account for the steady level of 
benzodiazepine use in Ireland is that no campaign on the dangers of inappropriate 
benzodiazepine usage has been active in the country in the last ten years, since the launch 
of the Benzodiazepine: Good Practice Guidelines for Clinicians document in 2002. Such a 
campaign could encourage a young person or their parents to ensure that prescription usage 
is within safe limits, and deter its illicit use. 
4.2. Limitations 
A limitation to this systematic review is that the conclusions are only as accurate as the 
studies it returns. This is a limitation with every systematic review and literature review. To 
minimise the impact of low quality studies on the review, it was decided to quantify the 
quality of the studies using the Methodological Index for NOn-Randomised Studies 
(MINORS) tool(Slim, et al., 2003). 
An important limitation in the studies in this review was the lack of consistency in survey 
design. An example of this is evident in Table 2 under the column “Tobacco use in the 
previous month”. It is a standard, internationally-used question used to estimate regular use 
of a substance. Some studies chose to survey regular use with questions such as “Are you 
currently smoking?” and “Do you smoke one or more cigarettes each week?” Each question 
is attempting to measure the same outcome but because of the differences in the actual 
questions, it makes cross-study comparisons inappropriate and difficult. This limitation 
affected the ability to make comparisons between studies surveying tobacco, alcohol, 
cannabis, and benzodiazepine use.  
There were few papers found in the literature search that surveyed benzodiazepine usage.  
A comprehensive search of scientific databases and grey literature could only find five 
relevant papers. Each of these studies measured usage superficially; one or two questions 
were asked as part of a section dealing with illicit substance use. It is difficult to get a clear 
understanding of benzodiazepine usage from these papers. It is important at present to look 
closer for patterns in benzodiazepine use because it was the only substance in this review 
whose usage did not appear to be decreasing. This could be the first stage in the 
development of a targeted educational campaign highlighting the dangers of inappropriate 
benzodiazepine usage. 
There is a category of young person that is excluded from most of the studies in this review. 
As can be seen in the „Notes‟ column in Table 1, twelve of the seventeen studies chose 
participants from pupils attending the schooling system in Ireland. This method of selection 
has many advantages; it is more efficient to randomly select young persons around the 
country, and it saves time because the students are all in the same place at the same time. 
However, this misses out on early school-leavers, who account for up to 14.1% of school-
leavers in total(D. Byrne, McCoy, & Watson, 2008). This cohort of young persons is a 
significant absence from any study reporting on substance use. International studies have 
shown that early school-leavers are more likely to use both legal and illegal 
substances(Townsend, Flisher, Gilreath, & King, 2006). Excluding this group has the 
potential to underreport the true level of substance use in young persons. 
4.3. Conclusions 
This review has shown that substance use is still occurring in Ireland. Much of the research 
that is being undertaken on this topic in Ireland is of high quality and it indicates that the level 
of use is declining across many substances. However, there is still further work that can be 
done by policy-makers to ensure that this positive trend will continue.  However, the fall in 
use is not evident with some substances and efforts must be increased to inform the public 
on their risks. Future work should redress the imbalance in substance use research that 
sees the majority of researchers looking at a few substances while little work is done on the 
others. Knowledge derived from these papers and reports, and from future work should 
guide the development of targeted drug prevention programs that are directed at the 
sections of population that will benefit the most from them. 
5. References 
Bellerose, D., Carew, A.-M., & Lyons, S. (2011). Trends in treated problem drug use in Ireland 2005 to 
2010 HRB Trends Series 12. Dublin: Health Research Board. 
Bould, M. D., Mahtani, D. G., Davies, R., Roughton, M., Hunter, D. N., & Kelleher, A. (2007). Bispectral 
index values during elective rigid bronchoscopy: A prospective observational pilot study. 
Anaesthesia, 62(5), 438-445.  
Byrne, C. (2011, 07/05/2011). Over 400 now in garda drug war frontline, The Herald.  
Byrne, D., McCoy, S., & Watson, D. (2008). School Leavers' Survey Report 2007. Dublin: Department 
of Education and Science. 
Central Statistics Office. (2011). Controlled drug offences.  Retrieved 1/12/2011 
Chen, C. Y., Storr, C. L., & Anthony, J. C. (2009). Early-onset drug use and risk for drug dependence 
problems. Addict Behav, 34(3), 319-322. doi: 10.1016/j.addbeh.2008.10.021 
Currie, C., Gabhainn, N. S., Godeau, E., Roberts, C., Smith, R., & Currie, D. (2008). Inequalities in 
Young People's Health: HBSC International Report From the 2005/2006 Survey. Copenhagen: 
WHO Regional Office for Europe. 
Curtin, M. (2004). Smoking and drinking among 15-16-year-old girls: Do male peers have an 
influence? Irish Journal of Medical Science, 173(4), 191-192.  
Dawson, D. A., Goldstein, R. B., Chou, S. P., Ruan, W. J., & Grant, B. F. (2008). Age at first drink and 
the first incidence of adult-onset DSM-IV alcohol use disorders. Alcohol Clin Exp Res, 32(12), 
2149-2160. doi: 10.1111/j.1530-0277.2008.00806.x 
Department of Community Rural and Gaeltacht Affairs. (2009). National Drugs Strategy (interim) 
2009-2016.  Dublin. 
Department of Health. (1991). Government Strategy To Prevent Drug Misuse.  Dublin: Eastern Health 
Board Retrieved from http://www.drugsandalcohol.ie/5108/1/535-0483.pdf. 
Department of Health and Children. (2002). Benzodiazepines: Good Practice Guidelines for Clinicians. 
Dublin: Department of Health and Children. 
Department of Tourism Sport & Recreation. (2000). Building on Experience, National Drugs Strategy 
2001 – 2008.  Dublin: Stationery Office. 
EMCDDA. (2011). Statistical Bulletin 2011: Drug-related deaths. Lisbon: European Monitoring Centre 
for Drugs and Drug Addiction. 
Faggiano, F., Vigna-Taglianti, F., Burkhart, G., Bohrn, K., Cuomo, L., Gregori, D., . . . Galanti, M. R. 
(2010). The effectiveness of a school-based substance abuse prevention program: 18-month 
follow-up of the EU-Dap cluster randomized controlled trial. Drug Alcohol Depend, 108(1-2), 
56-64. doi: 10.1016/j.drugalcdep.2009.11.018 
Faggiano, F., Vigna-Taglianti, F. D., Versino, E., Zambon, A., Borraccino, A., & Lemma, P. (2005). 
School-based prevention for illicit drugs' use. Cochrane Database Syst Rev(2), CD003020. doi: 
10.1002/14651858.CD003020.pub2 
Flanagan, E., Bedford, D., O' Farrel, A., & Howell, F. (2003). Smoking, Alcohol & Drug Use among 
Young People: North Eastern Health Board. 
Global Youth Tobacco Survey Collaborative Group. (2002). Tobacco use among youth: a cross 
country comparison. Tob Control, 11(3), 252-270.  
Gossop, M., Stewart, D., Treacy, S., & Marsden, J. (2002). A prospective study of mortality among 
drug misusers during a 4-year period after seeking treatment. Addiction, 97(1), 39-47.  
Gruber, S. A., Sagar, K. A., Dahlgren, M. K., Racine, M., & Lukas, S. E. (2011). Age of onset of 
marijuana use and executive function. Psychol Addict Behav. doi: 10.1037/a0026269 
Hart, C. L., Morrison, D. S., Batty, G. D., Mitchell, R. J., & Davey Smith, G. (2010). Effect of body mass 
index and alcohol consumption on liver disease: analysis of data from two prospective 
cohort studies. BMJ, 340, c1240.  
Hawkins, J. D., Graham, J. W., Maguin, E., Abbott, R., Hill, K. G., & Catalano, R. F. (1997). Exploring 
the effects of age of alcohol use initiation and psychosocial risk factors on subsequent 
alcohol misuse. J Stud Alcohol, 58(3), 280-290.  
Health Research Board. (2010). Drug-related deaths and deaths among drug users in Ireland, 1998 to 
2007. Data from the National Drug-Related Deaths Index. Dublin. 
Health Research Board. (2011a). Drug-related deaths and deaths among drug users in Ireland: 2009 
figures from the National Drug-Related Deaths Index. Dublin. 
Health Research Board (Cartographer). (2011b). Drug-related deaths and Drug-related deaths and 
deaths among drug users in Ireland: 2008 figures from the National Drug-Related Deaths 
Index. Retrieved from www.hrb.ie/publications/alcohol-drugs 
Health Research Board. (2011c). The National Documentation Centre on Drug Use - Drugs and 
Alcohol  Retrieved 13/12/2011, from http://www.drugsandalcohol.ie/ 
Hibell, B., Andersson, B., Bjarnason, T., Ahlstrom, S., Balakireva, O., Kokkevi, A., & Morgan, M. 
(2004). The ESPAD report 2003: alcohol and other drug use among students in 35 European 
countries. 
Hibell, B., Guttormsson, U., Ahlström, S., Balakireva, O., Bjarnason, T., Kokkevi, A., & Kraus, L. (2009). 
The 2007 ESPAD Report. Substance use Among Students in 35 European Countries. 
Stockholm: The Swedish Council for Information on Alcohol and Other Drugs CAN. 
Hibell, B., Guttormsson, U., Ahlström, S., Balakireva, O., Bjarnason, T., Kokkevi, A., & Kraus, L. (2012). 
The 2011 ESPAD Report: Substance Use Among Students in 36 European Countries (pp. 394). 
Stockholm: The Swedish Council for Information on Alcohol and Other Drugs. 
Kabir, Z., Manning, P. J., Holohan, J., Goodman, P. G., & Clancy, L. (2010). Active smoking and 
second-hand-smoke exposure at home among Irish children, 1995-2007. Archives of Disease 
in Childhood, 95(1), 42-45. doi: 10.1136/adc.2008.155218 
Kelleher, K., Cowley, H., & Houghton, F. (2003). Teenage smoking, alcohol and drug use in the Mid-
Western Health Board Region 2002: Mid-Western Health Board. 
Lewinsohn, P. M., Rohde, P., & Brown, R. A. (1999). Level of current and past adolescent cigarette 
smoking as predictors of future substance use disorders in young adulthood. Addiction, 
94(6), 913-921.  
Manning, P., Goodman, P., Kinsella, T., Lawlor, M., Kirby, B., & Clancy, L. (2002). Bronchitis symptoms 
in young teenagers who actively or passively smoke cigarettes. Irish Medical Journal, 95(7), 
202-204.  
McNeill, A., Lewis, S., Quinn, C., Mulcahy, M., Clancy, L., Hastings, G., & Edwards, R. (2011). 
Evaluation of the removal of point-of-sale tobacco displays in Ireland. Tobacco Control, 
20(2), 137-143. doi: 10.1136/tc.2010.038141 
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The, P. G. (2009). Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med, 6(7), e1000097. 
doi: 10.1371/journal.pmed.1000097 
Moran, A., Maguire, N., & Howell, F. (2000). Smoking and quitting among Irish teenage males. Irish 
Medical Journal, 93(9), 272-273.  
Morgan, K., McGee, H., Watson, D., Perry, I. J., Barry, M. J., Shelley, E., . . . Brugha, R. (2008). SLÁN 
2007: Survey of Lifestyle, Attitudes & Nutrition in Ireland. Main report.  Dublin. 
National Advisory Committee on Drugs. (2011). Drug use in Ireland and Northern Ireland, First results 
from the 2010/11 Drug Prevalence Survey.  Dublin:  Retrieved from 
http://www.nacd.ie/publications/drug_use_ireland.html. 
National Center for Biotechnology Information. (2011). Home - MeSH -NCBI  Retrieved 13/12/2011, 
from http://www.ncbi.nlm.nih.gov/mesh 
National Documentation Centre on Drug Use. (2012). About page  Retrieved 05/01/2012, from 
http://www.drugsandalcohol.ie/php/about.php 
O'Cathail, S. M., O'Connell, O. J., Long, N., Morgan, M., Eustace, J. A., Plant, B. J., & Hourihane, J. O. 
B. (2011). Association of cigarette smoking with drug use and risk taking behaviour in Irish 
teenagers. Addictive Behaviors, 36(5), 547-550. doi: 10.1016/j.addbeh.2011.01.012 
Office of Tobacco Control. (2006). Children, Youth and Tobacco: Behaviour, Perceptions and Public 
Attitudes. Naas: Office of Tobacco Control. 
Palmer, D., & O' Reilly, G. (2008). Young people, Alcohol and drugs: Juvenile Mental Health Matters. 
Schuppan, D., & Afdhal, N. H. (2008). Liver cirrhosis. Lancet, 371(9615), 838-851. doi: 10.1016/s0140-
6736(08)60383-9 
Share, M., Quinn, M., & Ryan, C. (2004). Evaluation of a 5-year school-based county-wide smoking 
education programme. Irish Medical Journal, 97(9), 266-267.  
Slim, K., Nini, E., Forestier, D., Kwiatkowski, F., Panis, Y., & Chipponi, J. (2003). Methodological index 
for non-randomized studies (minors): development and validation of a new instrument. ANZ 
J Surg, 73(9), 712-716.  
Smyth, B. P., Kelly, A., & Cox, G. (2011). Decline in age of drinking onset in Ireland, gender and per 
capita alcohol consumption. Alcohol and Alcoholism, 46(4), 478-484.  
Townsend, L., Flisher, A. J., Gilreath, T., & King, G. (2006). A systematic literature review of tobacco 
use among adults 15 years and older in sub-Saharan Africa. Drug and Alcohol Dependence, 
84(1), 14-27. doi: 10.1016/j.drugalcdep.2005.12.008 
Tucker, P. (2009). Substance misuse and early psychosis. [Article]. Australasian Psychiatry, 17(4), 
291-294. doi: 10.1080/10398560802657314 
UNICEF Ireland. (2011). Change the Future: Experiencing Adolescence in Contemporary Ireland: 
Alcohol and Drugs 2011. Dublin. 
Vega, W. A., Aguilar-Gaxiola, S., Andrade, L., Bijl, R., Borges, G., Caraveo-Anduaga, J. J., . . . Wittchen, 
H. U. (2002). Prevalence and age of onset for drug use in seven international sites: Results 
from the international consortium of psychiatric epidemiology. Drug and Alcohol 
Dependence, 68(3), 285-297.  
World Health Organisation. (2008). WHO Report on the Global Tobacco Epidemic, 2008: The 
MPOWER package. Geneva. 
World Health Organisation. (2009). Global Health Risks: Mortality and burden of disease attributable 
to selected major risks. Geneva. 
World Health Organisation. (2010). Global strategy to reduce the harmful use of alcohol.  Geneva. 
World Health Organisation. (2011). Global status report on alcohol and health. Geneva. 
 
 
Table 1
Click here to download high resolution image
Table 2
Click here to download high resolution image
Table 3
Click here to download high resolution image
Table 4
Click here to download high resolution image
Table 5
Click here to download high resolution image
Figure 1
Click here to download high resolution image
Role of funding sources 
Partial funding for this study was provided by Matt Talbot Services. 
 
Contributors 
SB, LS, and SL conceived the original idea for, and designed the review criteria. KM carried 
out the database searches and wrote the introduction, methods, results, discussion and 
conclusion. SB, LS, and SL reviewed all drafts and suggested modifications. All authors 
contributed to and have approved final manuscript. 
 
Conflict of interest 
All authors declare that they have no conflicts of interest. 
 
Acknowledgments 
We acknowledge the assistance of the staff of Matt Talbot Services in Trabeg and the 
Pharmaceutical Care Research Group in University College Cork. 
 
*Author Disclosures
